The Dutch national inhaler care pathway for patients with asthma/COPD: a hybrid type III implementation study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26085

Enrollment

500

Registered

2021-06-17

Start date

2021-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma, COPD Chronic Obstructive Pulmonary Disease, Asthma

Interventions

Inhalatie zorgpad implementatie

Other intervention

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: (i) patiënten >=18 jaar met astma en/of COPD (ii) gebruikend inhalatie medicatie voor minimaal 3 maanden; (iii) begrijpen Nederlandse taal

Exclusion criteria

Exclusion criteria: < 18 jaar, geen begrip Nederlandse taal

Design outcomes

Primary

Measure	Time frame
Barriers and facilitators for optimal implementation of the national inhaler care pathway	—

Secondary

Measure	Time frame
Clinical outcomes: relievers/controller ratio, medication adherence, uniformity in inhaler devices, exacerbations. Qualitative outcomes: Implementation of inhaler care pathway elements, agreements between healthcare providers made, time investment, patient satisfaction, healthcare provider satisfaction	—

Contacts

Public ContactJob Van Boven

University Medical Center Groningen

j.f.m.van.boven@umcg.nl+31503617893

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)